trimetazidine dihydrochloride Tablets, modified release (MR) 35 mg

Dossier type
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
Manufacturer #11542
It is one of the most rapidly expanding pharmaceutical enterprises in Europe. A cutting-edge pharmaceutical manufacturing plant and a laboratory with the highest-quality equipment are among the manufacturing facilities. The production lines and laboratories follow European standards, and a team of competent personnel ensures that these guidelines are followed. The manufacturing procedures meet all GMP regulations, whereas clinical trial goods are made per GLP and GMP principles.

Manufacturer usually replies in 8 days